Related Experiment Video
Updated: Jun 6, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Hemodynamic-based Assessment and Management of Cardiogenic Shock
Jaime Hernandez-Montfort1, Diana Miranda2, Varinder Kaur Randhawa3
1Department of Medicine, Division of Cardiology, Baylor Scott and White Health Temple, TX.
Insights
Cardiogenic shock (CS) is a severe condition causing organ damage due to poor blood flow. This study proposes an adaptive model for early identification and management transitions in CS patients.
Area of Science:
- Cardiology
- Critical Care Medicine
- Health Systems Science
Background:
- Cardiogenic shock (CS) is a life-threatening condition characterized by hypoperfusion and end-organ dysfunction.
- The management of CS presents significant challenges due to its complex pathophysiology and heterogeneity.
- Effective CS care requires a systematic approach to hemodynamic management.
Purpose of the Study:
- To propose an adaptive, longitudinal situational awareness model for managing cardiogenic shock.
- To outline considerations for systematic, hemodynamic-based transitions in CS patient care.
- To address the scalable heterogeneity in CS management from cellular to healthcare system levels.
Main Methods:
- The study presents a conceptual model for CS care, emphasizing adaptive longitudinal situational awareness.
- It discusses systematic transitions based on hemodynamic monitoring and patient status.
- Considerations for integrating cellular-level insights with healthcare system logistics are explored.
Main Results:
- The proposed model facilitates early identification and rapid transitions in CS patient management.
- It offers a framework for addressing the heterogeneity of CS across different care settings.
- The model aims to optimize resource utilization and clinical decision-making in CS.
Conclusions:
- An adaptive situational awareness model can guide systematic hemodynamic management in cardiogenic shock.
- Further research is needed to optimize drug and device strategies within integrated health systems for CS.
- Implementing such models may improve outcomes for patients with this critical condition.
Abstract:
Cardiogenic shock (CS) remains a deadly disease entity challenging patients, caregivers, and communities across the globe. CS can rapidly lead to the development of hypoperfusion and end-organ dysfunction, transforming a predictable hemodynamic event into a potential high-resource, intense, hemometabolic clinical catastrophe. Based on the scalable heterogeneity from a cellular level to healthcare systems in the hemodynamic-based management of patients experiencing CS, the authors present considerations towards systematic hemodynamic-based transitions in which distinct clinical entities share the common path of early identification and rapid transitions through an adaptive longitudinal situational awareness model of care that influences specific management considerations. Future studies are needed to best understand optimal management of drugs and devices along with engagement of health systems of care for patients with CS.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Pericarditis IV: Nursing Management
Rheumatic Heart Disease IV: Nursing Management
Aortic Regurgitation IV: Nursing Management
Mitral Regurgitation IV: Nursing Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

